Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/10/028521
CTRI/2020/10/028521
Not yet recruiting
未知

A pilot study to assess the effect of intraductal N acetyl cysteine on swallowing and voice outcomes of patients with oropharyngeal cancer undergoing radiotherapy.

ENT Department0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C10- Malignant neoplasm of oropharynx

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C10- Malignant neoplasm of oropharynx
Sponsor
ENT Department
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ENT Department

Eligibility Criteria

Inclusion Criteria

  • •1\.Clinically, radiologically and biopsy proven cases of oropharyngeal cancer,
  • •2\.Planned for radical radiotherapy,
  • •3\.Patients giving written informed consent

Exclusion Criteria

  • •1\.Patient not giving consent,
  • •2\. \<18 years, \>70 years,
  • •3\.Decreased mouth opening (Trismus),
  • •4\.Having undergone a total laryngectomy,
  • •5\.History of radiotherapy in Head and Neck area

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa.Retinitis Pigmetosa.MedDRA version: 19.0 Level: PT Classification code 10038914 Term: Retinitis pigmentosa System Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Body processes [G] - Genetic Phenomena [G05]
EUCTR2016-002523-28-GBMoorfields Eye Hospital1
Active, not recruiting
Not Applicable
A Pilot study investigating the use of Intravitreal Triamcinolone prior to macular laser for Clinically Significant Diabetic Macular Oedema - CSMO and triamcinoloneMacular oedema affects 29% of diabetic patients and is the main cause of visual impairment. Previous studies show that diffuse macular oedema carries a particularly poor prognosis despite laser photocoagulation.
EUCTR2004-005043-97-GBSt Mary's NHS Trust50
Not yet recruiting
Not Applicable
A pilot study assessing the effectiveness and safety of patient-controlled sedation during the insertion of a central venous line.Radiologically-guided insertion of a central venous line for patients undergoing chemotherapy, dialysis, or other conditions requiring high flow long term central line access (eg treatment of cystic fibrosis or other chronic disease)Anaesthesiology - Other anaesthesiology
ACTRN12614001280695Alfred Hospital10
Completed
Phase 1
A pilot study evaluating the safety of intravenously administered human amnion epithelial cells for the treatment of hepatic fibrosiscirrhosisliver fibrosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12616000437460Monash Health9
Completed
Phase 1
Amnion cells for the treatment of bronchopulmonary dysplasia in premature babies
ACTRN12614000174684Monash Health Research Directorate6